Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bilateral DLPC tDCS: a New Potential Neuromodulatory Strategy in Drug-resistant Migraine

NCT06079801 is registered in ClinicalTrials.gov with Clínica de Intervención en Neurociencias as lead sponsor.

NCT NCT06079801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06079801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bilateral DLPC tDCS: a New Potential Neuromodulatory Strategy in Drug-resistant Migraine
Lead sponsor
Clínica de Intervención en Neurociencias
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2021
Completion date
August 31, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine